ItalianoBARBOLINI, MONICA
Dettaglio
BARBOLINI, MONICA
Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto
Pubblicazioni
Risultati 1 - 20 di 24 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | Breast Location for De Novo Extramedullary Myeloid Sarcoma | 2018 | Tazzioli, Giovanni; Enza, Palma; Gambini, Anna; Messerotti, Andrea; Potenza, Leonardo; Luppi, Mario; Antonella, Drago; Maria Grazia Amorico, ; Barbolini, Monica; Guido, Ficarra; Piacentini, Federico |
| 2 | Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer | 2020 | Isca, Chrystel; Omarini, Claudia; Cortesi, Giulia; Moscetti, Luca; Barbolini, Monica; Dominici, Massimo; Piacentini, Federico |
| 3 | Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. | 2019 | Barbolini, M; Omarini, C; Viola, L; Isca, C; Marchi, I; Caggia, F; Barbieri, E; Toss, A; Cortesi, L; Dominici, M; Piacentini, F. |
| 4 | Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials | 2020 | Omarini, C.; Piacentini, F.; Sperduti, I.; Barbolini, M.; Isca, C.; Toss, A.; Cortesi, L.; Barbieri, E.; Dominici, M.; Moscetti, L. |
| 5 | A concise review of lenalidomide therapy for follicular lymphoma | 2017 | Bari, Alessia; Marcheselli, Raffaella; Barbolini, Monica; Ferri, Paola; Sacchi, Stefano; Pozzi, Samantha |
| 6 | Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. | 2019 | Omarini, C; Bettelli, S; Caprera, C; Manfredini, S; Barbolini, M; Moscetti, L; Isca, C; Toss, A; Barbieri, E; Cortesi, L; Kaleci, S; Maiorana, A; Tazzioli, G; Cascinu, S; Piacentini, F |
| 7 | Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial | 2019 | Omarini, C; Sperduti, I; Barbolini, M; Isca, C; Bocconi, Alessandro; Toss, A; Cortesi, L; Barbieri, E; Piacentini, F; Cascinu, S; Moscetti, L |
| 8 | Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. | 2019 | Omarini, Claudia; Piacentini, Federico; Sperduti, Isabella; Barbolini, Monica; Isca, Chrystel; Nasso, Cecilia; Toss, Angela; D'Onofrio, Raffaella; Cortesi, Laura; Barbieri, Elena; Cascinu, Stefano; Moscetti, Luca |
| 9 | The evolving role of microsatellite instability in colorectal cancer: A review | 2016 | Gelsomino, Fabio; Barbolini, Monica; Spallanzani, Andrea; Pugliese, Giuseppe; Cascinu, Stefano |
| 10 | GD2 expression in breast cancer. | 2017 | Orsi, Giulia; Barbolini, Monica; Ficarra, G; Tazzioli, Giovanni; Manni, Paola; Petrachi, Tiziana; Mastrolia, Ilenia; Orvieto, E; Spano, Maria Carlotta; Prapa, Malvina; Kaleci, Shaniko; D'Amico, Roberto; Guarneri, V; Dieci, Mv; Cascinu, Stefano; Conte, P; Piacentini, Federico; Dominici, Massimo |
| 11 | Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . | 2018 | Omarini, Claudia; Guaitoli, Giorgia; Barbolini, Monica; Moscetti, Luca; Balduzzi, Sara; Caggia, Federica; Cascinu, Stefano; Piacentini, Federico |
| 12 | Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. | 2019 | Palumbo, Patrizia; Draisci, Stefano; Barbolini, Monica; Nasso, Cecilia; Isca, Chrystel; Bocconi, Alessandro; Balduzzi, Sara; Pecchi, Annarita; Galetti, Silvia; Torricelli, Pietro; Piacentini, Federico; Moscetti, Luca; Cascinu, Stefano; Omarini, Claudia |
| 13 | Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. | 2020 | Barbolini, Monica; Omarini, Claudia; Toss, Angela; Cortesi, Giulia; Fiorani, Claudia; Piombino, Claudia; Dominici, Massimo; Piacentini, Federico |
| 14 | LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib | 2020 | Omarini, Caudia; Molinaro, Eleonora; Barbolini, Monica; Dominici, Massimo; Piacentini, Federico |
| 15 | Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy | 2020 | Omarini, Claudia; Bettelli, Stefania Raffaella; Manfredini, Samantha; Barbolini, Monica; Isca, Chrystel; Cortesi, Giulia; Maiorana, Antonino; Tazzioli, Giovanni; Dominici, Massimo; Piacentini, Federico |
| 16 | Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus | 2018 | Omarini, Claudia; Filieri, Maria Elisabetta; Bettelli, Stefania Raffaella; Manfredini, Samantha; Kaleci, Shaniko; Caprera, Cecilia; Nasso, Cecilia; Barbolini, Monica; Guaitoli, Giorgia; Moscetti, Luca; Maiorana, Antonino; Conte, Pierfranco; Cascinu, Stefano; Piacentini, Federico |
| 17 | Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. | 2019 | Omarini, C; Palumbo, P; Pecchi, A; Draisci, S; Balduzzi, S; Nasso, C; Barbolini, M; Isca, C; Bocconi, A; Moscetti, L; Galetti, S; Tazzioli, G; Torricelli, P; Cascinu, S; Piacentini, F. |
| 18 | Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. | 2020 | Barbolini, M.; Omarini, C.; Bettelli, S.; Manfredini, S.; Dominici, M.; Piacentini, F. |
| 19 | Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . | 2018 | Piacentini, F; Omarini, C; Garuti, G; Badea, M; Moscetti, L; Cortesi, L; Toss, A; Barbieri, E; Barbolini, M; Guaitoli, G; Caputo, F; Cascinu, S |
| 20 | Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. | 2020 | Nasso, C.; Barbolini, M.; Isca, C.; D'onofrio, R.; Cortesi, G.; Dominici, M.; Piacentini, F.; Omarini, C. |
Copyright © 2021